Study identifies two factors that may help patients benefit from off-the-shelf CAR T-cell therapies
Researchers at The University of Texas MD Anderson Cancer Center have traced how off-the-shelf chimeric antigen receptor (CAR) T cells behave in patients, revealing how immune rejection and differences among CAR T cells influence their ability to multiply after infusion.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Pupillary responses differ when judging glossiness and attractiveness
United Kingdom
-
Emerging therapies expand the treatment landscape for coronary artery disease
United Kingdom
-
Research advances understanding of tick-borne Powassan virus
United Kingdom
-
AI correction tone influences effectiveness in combating medical misinformation
United Kingdom
-
Shared neural noise may not limit the brain's information capacity
United Kingdom
-
Cystic fibrosis: Triple therapy is particularly effective in early childhood
United Kingdom
-
Virtual reality and classical music help to reduce blood pressure in patients in emergency department
United Kingdom
-
Drones could speed up delivery of automated external defibrillators to patients suffering cardiac arrest
United Kingdom